ZLZifan Li

Zifan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zifan Li has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chemical cleavage coupled with LCMS to report on the true diastereomeric distributions of phosphorothioate linkages in gapmer ASO

    by Zifan Li, Tai Nguyen, Xuan Zhou, Li Xiao, George M. Bou-Assaf

    Phosphorothioate (PS) modifications are commonly employed to enhance the performance of antisense oligonucleotides (ASOs). Each phosphorus atom at a PS linkage acts as a chiral center, typically resulting in thousands or more diastereomers in a therapeutic PS ASO. Since the synthesis of most PS ASOs under development is not stereo-selective, establishing stereochemical comparability between batches is crucial for ensuring the consistency of the drug substance. In this study, we evaluate a nuclease-free approach based on the Maxam-Gilbert sequencing and alkylation sequencing method to chemically cleave gapmer PS ASOs into smaller fragments to facilitate the chromatographic separation of diastereomers. Compared to our previous report using nuclease P1 coupled with liquid chromatography-mass spectrometry analysis, the chemical cleavage approach demonstrated superior repeatability and sensitivity in analyzing gapmer PS ASOs. Beyond comparability, this method can accurately report on the true diastereomeric distributions at certain PS linkages, which significantly benefits the comparison of stereochemistry pre- and post-purification. Graphical Abstract


  • Differentiation of n-1 Positional Isomers in Antisense Oligonucleotides with Orthogonal LCMS Methods

    by Zifan Li, Xiaoqing Kong, Xiao Zhou, Li Xiao, Rasika Phansalkar, Tai Nguyen, Thomas C. Pickel, David Cho, Xuan Zhou, George M. Bou-Assaf

    Investigating the origin of critical product-related impurities during solid-phase synthesis is essential to improving the quality of therapeutic oligonucleotides. In the synthesis of a 2'-O-[2-(methylamino)-2-oxoethyl] modified phosphorothioate antisense oligonucleotide (NMA PS ASO), we observed elevated levels of n minus NMA 5-methylcytosine (n-NMA MeC), where n is the full-length product (FLP). This impurity, which results from the deletion of any of the five NMA MeC residues in the oligonucleotide sequence, is the major contributor to the n-1 class of impurities. High-resolution mass spectrometry cannot differentiate positional isomers arising from specific nucleotide deletions, because they are isobaric. Here, we compare two orthogonal approaches for the accurate differentiation of five isomeric n-NMA MeC impurities in a NMA PS ASO sample: (1) desulfurization to enhance chromatographic separation of the individual components of the composite n-NMA MeC impurity, thus enabling straightforward quantitation via LCMS, and (2) direct fragmentation of n-NMA MeC impurities to calculate the content of individual standards using their distinctive MS/MS fragments. Our strategies established the feasibility of resolving up to five isomeric n-1 impurities and allowed us to mitigate the risk of their formation during synthesis. The study results revealed that low coupling efficiency occurred at the NMA MeC nucleotides toward the 5' end of the sequence, which provided valuable insights into the sequence-specific challenges associated with synthesis efficiency and guided us to implement more effective n-1 control measures during the oligonucleotide synthetic process.


  • Assessment of Stereochemical Comparability in Phosphorothioated Oligonucleotides by CD, 31P NMR, and NP1 Digestion Coupled to LC-MS

    by Nicholas R. Larson, Fei Tong, Zifan Li, Yueheng Zhang, Li Xiao, Xuan Zhou, Jonas P. Immel-Brown, George M. Bou-Assaf

    Substitution of a nonbridging oxygen for sulfur on the phosphodiester backbone of an oligonucleotide enhances its pharmacokinetic properties. This substitution creates a new chiral center at the phosphorus atom of the linkage. Oligonucleotides with >10 phosphorothioate linkages are therefore mixtures of thousands to hundreds of thousands of diastereomers. From a chemistry, manufacturing, and control perspective, it is essential to ensure manufacturing consistency and product quality by controlling the factors that influence stereochemistry during synthesis and by implementing the proper analytical tools to analyze the stereochemical composition of phosphorothioated oligonucleotides. Here, we evaluated three orthogonal methods─circular dichroism (CD), 31P-nuclear magnetic resonance (31P NMR), and nuclease P1 (NP1) digestion followed by liquid chromatography coupled to mass spectrometry (LC-MS)─for their sensitivity to detect a change in stereochemical composition and therefore their ability to monitor batch-to-batch stereochemical comparability. Whereas all three methods are able to detect changes in R/S composition, the NP1/LC-MS method demonstrates superior sensitivity compared to the spectroscopic methods (CD and 31P NMR) and allows spatial localization of the changes.


  • Open Access

    Establishing stereochemical comparability in phosphorothioate oligonucleotides with nuclease P1 digestion coupled with LCMS analysis

    by Zifan Li, Fei Tong, Li Xiao, Nicholas R. Larson, Xuan Zhou, Yueheng Zhang, Jonas P. Immel-Brown, George M. Bou-Assaf

    NP1 digestion coupled with UHPLC-HRMS can provide valuable information on stereochemical comparability between phosphorothioate oligonucleotides by examining digestion fragments.


  • Omission of column washing operations in the solid phase synthesis of oligonucleotides

    by Li Xiao, Thomas Pickel, Zifan Li, Dominic Luciano, Jing Yang, David Cho, Sophia Mac, Xianglin Shi, George Bou-Assaf, Firoz Antia, et al.

    Oligonucleotides are generally manufactured via a solid-phase nucleotide elongation process utilizing a four-step or three-step reaction cycle consisting of detritylation, coupling, sulfurization/oxidation and optional capping. Following each step, the solid support is rinsed with solvent to remove residual reagent and to prepare the growing oligonucleotide chain for the next synthetic manipulation. Reported herein is an investigation of the impact of column-washing operations on the quality of oligonucleotide synthesis in the three-step cycle process. Also described is a more sustainable synthetic protocol without column-washing after the coupling and sulfurization steps that provides material of similar quality compared to material from standard washing protocols. This improvement allows for an approximate 70% reduction in wash solvent use for a typical 18 to 20-mer oligonucleotide. For every kilogram of an oligonucleotide synthesized, >300 L of organic solvents are saved and Process Mass Intensity (PMI) for synthesis steps is decreased from >890 to ∼530.